Farmacosmo SpAMIL:COSMO -0.79%33 Net Margin % is -5.36% as of Dec. 2025. GuruFocus rates MIL:COSMO with a GF Score™ of 33/100 and a GF Value™ of €0.73 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Farmacosmo SpA ranks worse than 74.77% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Farmacosmo SpA's Net Income for the
six
months ended in Dec. 2025 was €-1.49 Mil. Farmacosmo SpA's Revenue for the
six
months ended in Dec. 2025 was €27.75 Mil. Therefore, Farmacosmo SpA's net margin for the quarter that ended in Dec. 2025 was -5.36%.
The historical rank and industry rank for Farmacosmo SpA's Net Margin % or its related term are showing as below:
MIL:COSMO'
s Net Margin % Range Over the Past 10 Years
Min: -7.96 Med: -3.28 Max: 0.85
Current: -7.96
MIL:COSMO's Net Margin % is ranked worse than 74.77% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 2.895
vs MIL:COSMO: -7.96
Farmacosmo SpA (MIL:COSMO) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Farmacosmo SpA Net Margin % Related Terms
Farmacosmo SpA Net Margin % Historical Data
* Premium members only.
The historical data trend for Farmacosmo SpA's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Farmacosmo SpA's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Farmacosmo SpA Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Farmacosmo SpA's Net Margin % distribution charts can be found below:
* The bar in red indicates where Farmacosmo SpA's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Farmacosmo SpA (MIL:COSMO) has a Net Margin % of -5.36% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Farmacosmo SpA and its competitors. According to the industry distribution chart, Farmacosmo SpA ranks #498 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 74.8%.
Is Farmacosmo SpA's Net Margin % too high?
Farmacosmo SpA's current Net Margin % is -5.36%. Based on the distribution chart, Farmacosmo SpA ranks #498 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Farmacosmo SpA has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Farmacosmo SpA's Net Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Farmacosmo SpA ranks #498 out of 666 companies for Net Margin %. This places Farmacosmo SpA in the lower half of its industry. The industry median Net Margin % is 2.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.90, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Farmacosmo SpA and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farmacosmo SpA's current Net Margin % is -5.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmacosmo SpA stock overvalued right now?
Based on GuruFocus' analysis, Farmacosmo SpA (MIL:COSMO) is currently considered Possible Value Trap. The stock's GF Value™ is €0.73, compared to a current price of €0.50 — trading 31.2% below its estimated fair value. The current Net Margin % is -5.36%. Farmacosmo SpA's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Farmacosmo SpA (MIL:COSMO), the current Net Margin % is -5.36% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Farmacosmo SpA (MIL:COSMO) Overvalued in 2026?
Based on GuruFocus' analysis, Farmacosmo SpA stock appears to be undervalued.
The current stock price of €0.50 is trading 31.2% below its estimated GF Value™ of €0.73.
GuruFocus considers Farmacosmo SpA to be Possible Value Trap.
Key valuation signals for MIL:COSMO:
Net Margin %: -5.36%
GF Value™: €0.73 vs. price of €0.50 (31.2% below fair value)
No single metric tells the full story. See the MIL:COSMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Farmacosmo SpA is a wellness e-commerce company active in the Health, Pharma, and Wellness industry, authorized by the Italian Ministry of Health to sell pharmaceutical products online. In particular, the company offers parapharmaceutical products, vitamins and food supplements, dietetic products, medical devices, cosmetic products, personal hygiene products, hair care products, dental care products, skincare products, perfumes, home and baby items.
33GF Score
Get the complete analysis for MIL:COSMO
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:COSMO has been successfully added to your 
